Identification of Glycomic Alterations During Melanoma Metastasis

Abstract

We hypothesized that the ability of melanoma cells to abandon the primary site, survive, and grow in distal organs requires changes in glycosylation, some of which are site-specific. Our primary objective is to identify glycomic changes in melanoma that: 1) predict the ability of primary melanoma to metastasize and 2) promote colonization of distal organs, and particularly the brain. In the first year of funding we have obtained a large cohort of primary and metastatic melanomas (to different sites of metastasis) which we will examine for glycan profiling (Aim 1). This analysis is expected to reveal glycan signatures associated with metastasis in general, or to organ-specific tropism. On the other hand, we have conducted in vivo experiments that have provided further evidence of the ability of FUT8 inhibition to interfere with the growth of already established metastasis (Aim2). These findings support the development of FUT8 inhibitors as new therapeutic agents for melanoma treatment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Dec 01, 2020
Accession Number
AD1128362

Entities

People

  • Eva Hernando-monge

Organizations

  • Grossman School of Medicine

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Cancer
  • Cell Line
  • Cells
  • Cellular Structures
  • Data Analysis
  • Department Of Defense
  • Diseases And Disorders
  • Identification
  • Inhibitors
  • Lymph Nodes
  • Lymphatic System
  • Medical Personnel
  • Melanoma
  • Neoplasms
  • New York
  • Procurement
  • Sites
  • Students
  • Therapy

Fields of Study

  • Medicine

Readers

  • Immunology
  • Oncology
  • Oncology (Cancer Research).